Home › Funds › Bellevue Group AG › IRON
Bellevue Group AG position in IRON
DISC MEDICINE INC · Health Care
Bellevue Group AG reported holding 560,000 shares of IRON (DISC MEDICINE INC) in its Q2 2026 13F filing — a position valued at US$41.0M, representing 0.86% of its reported portfolio and ranking #33 among its reported holdings. Bellevue Group AG has disclosed IRON holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's IRON position evolved
Bellevue Group AG first disclosed a stake in IRON in Q1 2026 at 459,314 shares (US$29.4M). The position peaked in Q2 2026 at 560,000 shares, worth US$41.0M. Across 2 filings, Bellevue Group AG increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 560,000 shares valued at US$41.0M — an increase of 100,686 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 459.31K | $29.37M | New |
| Q2 2026 | 560.00K | $40.96M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRON and 13F data
IRON (DISC MEDICINE INC) is a Health Care company. 41 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Atlas Venture Life Science Advisors, LLC (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRON
- RA CAPITAL MANAGEMENT, L.P. 2.45M sh · $179.21M · Q2 2026
- Vestal Point Capital, LP 1.55M sh · $113.37M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 1.51M sh · $110.72M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.35M sh · $99.09M · Q2 2026
- TCG Crossover Management, LLC 1.34M sh · $98.14M · Q2 2026
- BVF INC/IL 1.15M sh · $84.38M · Q2 2026
- Siren, L.L.C. 888.40K sh · $64.98M · Q2 2026
- Logos Global Management LP 875.00K sh · $64.00M · Q2 2026
- Opaleye Management Inc. 855.00K sh · $62.53M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 657.00K sh · $48.05M · Q2 2026
- Saturn V Capital Management LP 524.73K sh · $38.38M · Q2 2026
- ARMISTICE CAPITAL, LLC 460.00K sh · $33.64M · Q2 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held IRON?
Bellevue Group AG has disclosed IRON holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Bellevue Group AG's current position in IRON?
As of Q2 2026, Bellevue Group AG holds 560.00K shares of IRON (DISC MEDICINE INC), valued at $40.96M, representing 0.86% of its reported portfolio and ranking #33.
Has Bellevue Group AG been buying or selling IRON?
In the latest 13F filing (Q2 2026), Bellevue Group AG increased its position in IRON. The position peaked in Q2 2026 at 560.00K shares.
Which other funds hold IRON?
Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Atlas Venture Life Science Advisors, LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.